Researchers will test several drugs at once to speed up identification of those that slow or reverse symptoms
Doctors in the UK are to launch a world-first clinical trial to assess whether drugs already on the market can prevent multiple sclerosis (MS) from worsening over time and even reverse the disabilities it causes.
The groundbreaking Octopus trial, so named because of its various arms, will allow researchers to investigate the potential benefits of several drugs at once, in the hope of identifying effective new treatments three times faster than if the medicines were trialled separately.
